PharmaMar begins phase II trial with anti-tumour drug PM184 in advanced breast …

PharmaMar begins phase II trial with anti-tumour drug PM184 in advanced breast …

PharmaMar, a world-leading biopharmaceutical company in the discovery and development of innovative marine – derived anticancer drugs, has announced the start of an open – label multi – centre two – stage phase II trial with the anti-tumour drug PM184.

(Visited 1 times, 1 visits today)
9
Like
Save

Comments

Comments are disabled for this post.